Translating peptides into small molecules.

[1]  P. Charifson,et al.  Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.

[2]  Tohru Koike,et al.  Computer-aided design of a factor Xa inhibitor by using MCSS functionality maps and a CAVEAT linker search. , 2003, Journal of molecular graphics & modelling.

[3]  V. Hruby.  Designing peptide receptor agonists and antagonists , 2002, Nature Reviews Drug Discovery.

[4]  Herman W. T. van Vlijmen,et al.  Identification of Potent and Novel α4β1 Antagonists Using in Silico Screening , 2002 .

[5]  T. Klabunde,et al.  Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. , 2002, Journal of medicinal chemistry.

[6]  L. Presta,et al.  Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. , 2002, Science.

[7]  Albert Loffet,et al.  Peptides as Drugs: Is There a Market? , 2002, Journal of peptide science : an official publication of the European Peptide Society.

[8]  K. Jarnagin,et al.  Structure-based design of six novel classes of nonpeptide antagonists of the bradykinin B2 receptor. , 2000, Bioorganic & medicinal chemistry letters.

[9]  V J Hruby,et al.  Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. , 2000, Current medicinal chemistry.

[10]  J. Kihlberg,et al.  Synthesis of Conformationally Restricted Mimetics of γ‐Turns and Incorporation into Desmopressin, an Analogue of the Peptide Hormone Vasopressin , 1999 .

[11]  J W Szostak,et al.  RNA-peptide fusions for the in vitro selection of peptides and proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Dower,et al.  An in vitro polysome display system for identifying ligands from very large peptide libraries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Thomas Rawson,et al.  From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold , 1994 .

[14]  Robert S. McDowell,et al.  From Peptide to Non-Peptide. 1. The Elucidation of a Bioactive Conformation of the Arginine-Glycine-Aspartic Acid Recognition Sequence , 1994 .

[15]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[16]  W. C. Ripka,et al.  Protein β-turn mimetics I. Design, synthesis, and evaluation in model cyclic peptides. , 1993 .

[17]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[18]  R. Houghten,et al.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.

[19]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[20]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Scheraga,et al.  Chain reversals in proteins. , 1973, Biochimica et biophysica acta.

[22]  J. Schneider-Mergener,et al.  Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. , 2000, Biopolymers.

[23]  Michael G. C. Kahn.  Peptide Secondary Structure Mimetics: Recent Advances and Future Challenges , 1993 .

[24]  M. Feigel.  2,8-Dimethyl-4-(carboxymethyl)-6-(aminomethyl)phenoxathiin S-dioxide: an organic substitute for the .beta.-turn in peptides? , 1986 .